Renal Cancer - Results from #1320

An Evaluation of a Web-Based Decision Aid for Treatment Planning of Small Kidney Tumors: Pilot Randomized Controlled Trial. September 7, 2022

Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors. September 7, 2022

Digital transformation of perioperative nurse-coordinated protocols in renal surgery for enhanced recovery and outpatient surgery using UroConnect® application. September 6, 2022

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. September 6, 2022

Immune checkpoint receptor VISTA on immune cells is associated with expression of T-cell exhaustion marker TOX and worse prognosis in renal cell carcinoma with venous tumor thrombus. September 5, 2022

Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial. September 5, 2022

Artificial intelligence for renal cancer: From imaging to histology and beyond. September 2, 2022

Improved Survival of Real-world Japanese Patients With Advanced Renal Cell Carcinoma Treated With Immuno-oncology Combination Therapy. September 2, 2022

New imaging technologies for robotic kidney cancer surgery. September 1, 2022

Efficacy and safety of surgery in renal carcinoma patients 75 years and older: a retrospective analysis. September 1, 2022

Association of C-reactive protein with efficacy of avelumab plus axitinib in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101. August 31, 2022

The controversial role and therapeutic development of the m6A demethylase FTO in renal cell carcinoma. August 31, 2022

Potential benefit of lymph node dissection during radical nephrectomy for kidney cancer: A review and critical analysis of current literature. August 31, 2022

A prognosis model for clear cell renal cell carcinoma based on four necroptosis-related genes. August 30, 2022

Assessing Trifecta Achievement after Percutaneous Cryoablation of Small Renal Masses: Results from a Multi-Institutional Collaboration. August 30, 2022

Adding Cyclooxygenase Inhibitors to Immune Checkpoint Inhibitors Did Not Improve Outcomes in Metastatic Renal Cell Carcinoma. August 30, 2022

The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature. August 30, 2022

Construction and validation of a novel ten miRNA-pair based signature for the prognosis of clear cell renal cell carcinoma. August 29, 2022

Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma. August 29, 2022

Analysis of Trifecta Results in a Single-Center Experience with Retroperitoneoscopic Partial Nephrectomy: An Observational Study. August 26, 2022

Page 67 of 456